FDA approves the first drug designed to treat postpartum depression

Tuesday, March 19, 2019 - 20:50 in Health & Medicine

The Food and Drug Administration on Tuesday approved the first drug specifically for postpartum depression, a debilitating condition that affects about 400,000 women a year in the United States. The disorder, which begins during pregnancy or within a month of childbirth, is far more severe than...

Read the whole article on LA Times - Science

More from LA Times - Science

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net